Patent · US Active

Transposition of native chromatin for personal epigenomics

US10889859B2 · kind B2 · utility

18Cited by
27References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2020
Grant dateJan 12, 2021
Priority date
Expiry dateJul 1, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein is a method for analyzing polynucleotides such as genomic DNA. In certain embodiments, the method comprises: (a) treating chromatin isolated from a population of cells with an insertional enzyme complex to produce tagged fragments of genomic DNA; (b) sequencing a portion of the tagged fragments to produce a plurality of sequence reads; and (c) making an epigenetic map of a region of the genome of the cells by mapping information obtained from the sequence reads to the region. A kit for performing the method is also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.